The curcumin question

Does the darling ingredient face a downfall?

In the supplement business, the troubling truth is that success breeds failure. A promising ingredient gets into the hands of a marketing team that overpromises benefits. The hype fuels a hit. Demand slams supply and the resulting collision leaves adulteration in the debris. Differentiation in the name of innovation drives questionable science and questionable claims in the black box war of bioavailability.

And to regulators and the media, it’s opposite

All access premium subscription

This content requires a subscription to Nutrition Business Journal.

As an NBJ subscriber, you receive 10 issues a year and access to the exclusive “NBJ subscriber only” content on newhope.com (excludes three-month subscriptions), which includes PowerPoint presentations, select data charts and archived articles. Subscribers also receive a 10 percent discount on data charts, comprehensive market research reports and webinars.

Email [email protected] for more information about subscribing.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.